Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Minim Invasive Ther Allied Technol. 2022 Mar;31(3):325-331. doi: 10.1080/13645706.2020.1818582. Epub 2020 Sep 23.
The prevalence of obesity has been increasing on a global scale. However, less than 1% of patients eligible for bariatric surgery actually undergo weight loss surgery. Endobariatric therapies (EBTs) have emerged to bridge the obesity treatment gap, as they are less invasive, highly effective, and more broadly applicable to patients with mild to moderate obesity. Endoscopic sleeve gastroplasty and primary obesity surgery endoluminal are the two most promising EBTs, altering stomach physiologies mimicking bariatric surgery. This review focuses on these two EBT approaches.
肥胖症的患病率在全球范围内呈上升趋势。然而，实际上只有不到 1%的肥胖症患者符合接受减重手术的条件。内减肥治疗（EBTs）的出现填补了肥胖症治疗的空白，因为它们的侵入性较小、效果显著，并且更广泛地适用于轻度至中度肥胖症患者。内镜胃袖状成形术和原发性肥胖症手术内镜腔内治疗是两种最有前途的 EBT 方法，它们改变了胃的生理机能，模拟了减重手术。本综述重点介绍了这两种 EBT 方法。
